Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript

Y Kunieda1, M Okabe, M Kurosawa

  • 1Third Department of Internal Medicine, School of Medicine, Sapporo, Japan.

Annals of Hematology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 116, 122301 (2016)].

Physical review letters·2025
Same author

Measurement of Direct-Photon Cross Section and Double-Helicity Asymmetry at sqrt[s]=510  GeV in p[over →]+p[over →] Collisions.

Physical review letters·2023
Same author

Unsustained Response to Benralizumab in Eosinophilic Asthma After 3 Years of Therapy With Mepolizumab.

Journal of investigational allergology & clinical immunology·2020
Same author

Erratum: Evolution of π^{0} Suppression in Au+Au Collisions from sqrt[s_{NN}]=39 to 200 GeV [Phys. Rev. Lett. 109, 152301 (2012)].

Physical review letters·2020
Same author

Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.

Journal of investigational allergology & clinical immunology·2019
Same author

Familial clustering of hypereosinophilic diseases treated with mepolizumab: a case report from Japan.

European annals of allergy and clinical immunology·2019
Same journal

Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in Greece.

Annals of hematology·2026
Same journal

Comparative thromboembolic risk of romiplostim versus eltrombopag in immune thrombocytopenia: a propensity score-matched cohort study.

Annals of hematology·2026
Same journal

Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024).

Annals of hematology·2026
Same journal

Early versus standard anti-thymocyte globulin administration in haploidentical transplantation using post-transplant cyclophosphamide: a pilot comparative study.

Annals of hematology·2026
Same journal

Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS dissemination.

Annals of hematology·2026
Same journal

A systematic review of 47 published cases of extramedullary hematopoiesis in myelofibrosis: clinical patterns, treatment responses, and prognostic implications.

Annals of hematology·2026
See all related articles

This study on chronic myeloid leukemia (CML) found that the P190-type BCR-ABL transcript, detected via RT-PCR, may influence unique clinical and hematological profiles in patients. Further investigation into these specific CML cases is warranted.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome (Ph1).
  • The BCR-ABL fusion gene is a hallmark of Ph1-positive CML.
  • Different BCR-ABL transcripts (P210 and P190) exist, with varying clinical implications.

Purpose of the Study:

  • To investigate BCR gene breakpoints in Ph1-positive CML cases.
  • To correlate BCR-ABL transcript types with clinical and hematological findings.
  • To explore the significance of the P190-type transcript in CML.

Main Methods:

  • Southern blot analysis for BCR gene rearrangement.
  • Reverse transcription-polymerase chain reaction (RT-PCR) for BCR-ABL transcript detection.

Related Experiment Videos

  • Analysis of hematological profiles in CML patients.

    • Main Results:

    • BCR breakpoints were not identified on M-bcr in three CML cases.
    • One case showed a P210-type BCR-ABL transcript.
    • Two cases exhibited P190-type BCR-ABL transcripts, with or without P210, and unique hematological profiles including thrombocytosis and myelofibrosis.

    Conclusions:

    • The P190-type BCR-ABL transcript may be associated with distinct clinical and hematological features in CML.
    • These findings suggest a potential role for P190-type transcript expression in CML pathogenesis and presentation.
    • Further research is needed to fully elucidate the impact of P190-type transcripts on CML patient outcomes.